CMS 1965 (expanded 1972) β CHIP 1997 β ACA 2010.Sources: Sync 3 Lecture; Module 2 CH 26 (Healthcare Delivery Systems).
| Stark Law (Physician Self-Referral) | Anti-Kickback Statute (AKS) | |
|---|---|---|
| Who | Physicians only | Anyone (hospitals, pharma, device, marketers) |
| Prohibits | Self-referral to entities with a financial relationship | Remuneration for referrals / business |
| Intent | Strict liability β no proof of intent needed | Requires proof of intent |
| Safe harbors / exceptions | In-office ancillary services; bona-fide FMV employment (not volume-based); short-term written leases; value-based (outcome-focused) arrangements | Bona-fide W-2 employment; written personal-service/IC contracts β₯1 yr at FMV; written space/equipment rental at FMV; EHR donation (with caps/cost-sharing) |
Sources: Sync 3 Lecture; Payment Regulation & CRNA Practice (Santoro).
Total Payment = (Base Units + Time Units) Γ CFPressures: No Surprises Act implementation, the stipend/subsidy crisis, state supervision/opt-out variation, workforce shortages, payer reductions (reduced QZ reimbursement, discontinued PS modifiers, medical-direction/concurrency errors), and the proposed anesthesia time cap.
| Physical Status | ABU* | Qualifying Circumstance | ABU/Modifier |
|---|---|---|---|
| P3 severe systemic disease | 1 | Induced hypotension | +5 |
| P4 constant threat to life | 2 | Induced hypothermia | +5 |
| P5 moribund | 3 | Emergency | +2 |
| Extreme age (<1 or >70) | 1 | Locum tenens (MDA only) | Q6 |
| MAC | QS | MAC deep/complex/markedly invasive | G8 |
| MAC + severe cardio-pulmonary hx | G9 | ||
*ABU = additional base units. Reminder: Medicare doesn't pay these modifying units, but commercial payers may.
Source: Payment Regulation & CRNA Practice (P. Santoro).
| Modifier | Meaning | Payment |
|---|---|---|
| AA | Anesthesia personally performed by anesthesiologist | 100% |
| QY | MD medical direction of ONE CRNA | 50% |
| QK | MD medical direction of 2β4 concurrent cases | 50% (physician side) |
| QX | CRNA service WITH medical direction | 50% |
| QZ | CRNA service WITHOUT medical direction (independent) | 100% |
| AD | MD medical supervision, >4 concurrent procedures | 3 units (max 4 if present for induction) |
| GC | Anesthesiologist teaching a resident | β |
| (none) | CRNA teaching an RRNA/SRNA β no billing modifier | β |
| Medical Direction | Medical Supervision | Physician Supervision | |
|---|---|---|---|
| Reimbursement | Part B (professional) | Part B (professional) | Part A (facility) |
| Ratio | MDA directs up to 4 CRNAs | MDA supervises >4 CRNAs | N/A |
| Rule | Must meet all 7 TEFRA steps β QK | Decreased reimbursement β AD | Condition for the hospital to be paid; states may OPT-OUT |
A directing MDA may step away for these without breaking medical direction: address an emergency of short duration Β· place a labor epidural Β· periodically monitor an OB patient Β· receive patients entering the suite for the next case Β· check on/discharge PACU patients Β· coordinate scheduling. (A prolonged airway rescue in another OR is not interruptible β QZ.)
For medical direction of 2β4 concurrent cases (QK), the anesthesiologist must satisfy ALL seven:
Source: Payment Regulation & CRNA Practice; Quiz 1 Review.
Under MACRA, clinicians choose one of two pay-for-performance pathways:
Combines four P4P inputs into a single Composite Performance Score (weighted average) β determines a payment adjustment (bonus/penalty).
CMS quality domains (map MIPS/APM measures to national priorities): Clinical Β· Safety Β· Care coordination Β· Person & caregiver-centered experience/outcomes Β· Population/community health Β· Efficiency & cost reduction.
Source: New Payment Models β MIPS and APMs.
Assets = Liabilities + Net Worth β Net Worth = Assets β Liabilities| Timing | Method | Basis |
|---|---|---|
| After service | Fee-for-service | Price charged |
| Discounted FFS β cost reimbursement | Contracted discount | |
| Per-case | Flat fee based on DRG | |
| Per diem | Number of days | |
| Before service | Capitation | Predetermined PMPM (per-member-per-month), by patients obligated to cover |
| Cash basis | Accrual basis (most common in healthcare) |
|---|---|
| Recorded when cash received/paid | Revenue recorded when earned; expense when incurred (not when paid) |
| Direct view of bank; poor at profitability over time; used for small-business tax reporting | Matches revenue with expenses β truer financial picture; used for large/complex orgs & financial statements |
Sources: Module 2 (Assets/Liabilities/Revenues/Expenses); Business of Anesthesia.
Goal of all four: determine the financial health of the organization.
| Statement | Question answered | Time frame | Core formula/idea |
|---|---|---|---|
| Income Statement | More income than expenses? | Period of time | Total revenue β total expenses = Net income |
| Balance Sheet | What we own, owe, and are worth | Point in time (usually FY-end) | Assets = Liabilities + Net worth |
| Statement of Changes in Net Worth | How equity/fund balance changed | Fiscal year | The link between income statement & balance sheet (net income flows into fund balance) |
| Cash Flow Statement | Where cash came from / went | Given period | Reconciles accrual β cash (adds back non-cash items like depreciation) |
Revenue β COGS β Gross profit (Revenue β COGS) β Operating expenses β Operating income (Gross profit β OpEx) β interest & taxes β Net income. Analyze via trend analysis, margin analysis (e.g., gross margin = gross profit/revenue), and a cash-flow check.
Source: Business of Anesthesia (Reporting performance).
| Direct | Indirect (overhead) |
|---|---|
| Traceable to a specific cost object (unit/department/patient/case) | Cannot be traced to one object; benefits overall operation β must be allocated |
| Anesthetic gases/meds, CRNA salary, anesthesia machine | Scheduling time across ORs, billing, administration |
Avg fixed cost = Total fixed cost Γ· total patients (falls as spread over more patients)Avg variable cost = Total variable cost Γ· total patientsAvg total cost = Total cost Γ· total patientsMarginal cost = ΞTotal cost Γ· ΞOutputSource: Module 4 (Ch 7 & 8).
1 FTE = 40 hrs/wk Γ 52 wks = 2,080 hrs/yr β includes both productive & non-productive time. Two half-time employees = 1 FTE.| Annualizing (burden approach) | Scheduled-position method | |
|---|---|---|
| Use | Full annual cost of a position | How many employees to fill a scheduled slot (planning new programs) |
| Non-productive time | Already built into the formula | Must burden the base rate by a % for non-productive time |
| Coverage factor | Net paid days β a factor | 7-day vs 5-day coverage = factor of 1.4 |
factor = 364 Γ· net paid days worked β RN 364/220 = 1.6545 Β· LPN 1.6396 Β· CNA 1.6323.Employee turnover = new hires Γ· total FTEs β review regularly; excessive turnover is costly.Source: Module 4 (Ch 9), incl. figures recovered by OCR.
Supplies β 10% and equipment/facilities β 4% of total hospital expenses.
Beginning inventory + Purchases = Cost of goods available for saleCost of goods available for sale β Ending inventory = COGSGross margin = Sales revenue β COGS
| Method | Rule | When costs are RISING |
|---|---|---|
| FIFO (first-in, first-out) | Oldest costs β COGS first | Ending inventory higher (old cheap items left... wait: oldest moved OUT, so ending inventory reflects newer, costlier items β higher) |
| LIFO (last-in, first-out) | Newest costs β COGS first | Ending inventory lower (older, cheaper items remain) |
| Weighted average | Cost of goods available for sale Γ· units available | Between FIFO & LIFO |
Captures supplies purchased but neither sold nor recorded (spoilage, misplacement, theft) by comparing ending vs. actual inventory; compare to benchmarks to trigger action.
Net Book Value = Original cost β Reserve for DepreciationSource: Module 4 (Ch 10).
| Incremental budget | Flexible budget |
|---|---|
| Based on forecasted output (often last year adjusted for volume) | Preliminary budget on forecast, then "flexed"/restated at period-end when actual output is known |
| Does not change when actual output differs | Re-estimates revenue/expense on actual output β avoids too many/few resources |
| Best when output is predictable year to year | Best when accurate forecasting is difficult |
Source: Business of Anesthesia (Budgets); speaker notes.
| FDIC INSURED | NOT FDIC insured |
|---|---|
| Checking & money market deposit accounts; savings/passbook; CDs | Mutual funds, annuities, stocks, bonds, treasury securities, other investment products |
FDIC = independent U.S. agency insuring bank/thrift deposits; preserves public confidence, limits failure fallout.
| Bonds | Stocks | |
|---|---|---|
| Nature | Long-term debt instrument (liability) | Equity/net worth |
| Holder is | Creditor | Owner/investor |
| Return | Interest during term + principal at maturity (20β30 yr) | Dividends / capital appreciation |
| Types | Municipal (capital projects), Mortgage (secured by property), Debenture (unsecured, backed by revenues) | Preferred, Common |
| Lease-purchase (capital / financial lease) | Operating lease | |
|---|---|---|
| Substance | A purchase in disguise β capitalize onto balance sheet (asset + liability) | Use for a period; stays lessor's property |
| Accounting | Recorded as asset/liability | Operating expense in the payment period; not capitalized |
Capitalize the lease if ANY criterion is met: (1) bargain purchase option at end; (2) ownership transfers before lease expires; (3) lease β₯ 75% of asset's useful life; (4) present value of payments β₯ 90% of asset value.
Source: Sync 3 Lecture (Capital Investments).
| Element | Definition |
|---|---|
| Mission | The PURPOSE of the organization (revisited every 3β5 yrs) |
| Vision | Clear, aspirational; follows mission; guides decisions |
| Values | Express the org's philosophy |
| Goals | Broad statements of purpose tied back to mission |
| Objectives | Intended outcomes; each ties to a strategic goal |
| Action/performance plans | Detailed operations showing how objectives are met + performance measures |
Planning is a never-ending cycle: plan β intervene β evaluate β revise. Broad goals β narrower objectives β action plans β performance measures. Internal & external stakeholders give input.
Source: Module 3 (Healthcare Landscape & Strategic Planning).
Defects Β· Time waste/idleness Β· Overproduction Β· Excess inventory Β· Excessive motion Β· Excessive transportation Β· Unnecessary processing Β· Underutilized talent.
Define β Measure β Analyze β Improve β Control β structured process to identify opportunities & implement improvements and avoid common change pitfalls.Sources: CH 16 (Benchmarking/Estimates); Using Lean Six Sigma (A3 figures recovered by OCR).
| Structure | Liability | Tax / notes |
|---|---|---|
| Sole proprietor | No separation β personal assets exposed | Simplest; no separate entity |
| Partnership (LP) | One partner liable; others limited | Per partnership agreement |
| LLP | Every owner has limited liability; protected from other partners' actions | β |
| LLC | Shields personal assets; creditors can't pursue owners' personal assets | Tax flexibility (pass-through or elect S-corp); less paperwork, no BOD/annual meetings required; must pay self-employment tax (Medicare/SS) |
| C-corp | Strongest personal protection | Separate legal entity; double taxation possible; costly record-keeping; can raise capital via stock |
| S-corp | Liability protection | Pass-through taxation (avoid corp tax); reasonable salary rule then distributions (self-employment tax savings); IRS Form 2553; K-1 to shareholders; strict rules; not recognized in all states |
Discovery & opportunity β Business planning β Resourcing β Execution & launch β Growth & management. Motivators: values/fulfillment, autonomy/control, goals/purpose, vision. Sell yourself via personal brand (credibility, competence, trustworthiness, character) and a practiced elevator pitch (identify self & goal β what you do β unique selling proposition β engage with a question β close with an "ask").
Source: Business of Anesthesia; speaker notes.
| Reason | Approx. share |
|---|---|
| Inadequate service levels (ORs closed for staffing, can't expand) | ~46% |
| Cost (subsidy needed; 2022 median U.S. hospital operating margin = β3.8%; <β positive) | ~38% |
| Incompetent/inadequate leadership | ~16% |
| Poor outcomes | Least common |
Signs an RFP is coming: contract term/renewal near Β· unscheduled CEO/COO/CMO meetings Β· poor financial performance Β· increasing subsidy requests Β· requests for detailed financials Β· increasing out-of-network billing Β· patient complaints/quality issues Β· difficult surgeon relationships.
Anesthesia Revenue β Anesthesia Expenses = Subsidy Drivers: case volume, case mix, case times, service levels, payer-policy changes, administrative duties.Opt-out: physician supervision is a Part A condition for hospital payment; states may opt out (full, partial, or none) β this is separate from Part B medical direction/supervision.
| Revenue inputs | Expense inputs |
|---|---|
| Case volume, case mix, payer mix, case times, contract rates/CF, payer policies, patient responsibility, stipends/subsidies, bundled/global fees | Service levels/OR efficiency, total comp (wage + benefits), taxes/fees, slow-surgeon case times, admin/clinical/non-clinical duties, payment delays, bad debt |
Source: Business of Anesthesia (RFP section).
Total Payment = (Base Units + Time Units) Γ CF (Medicare; ASA adds modifying units)Assets = Liabilities + Net WorthNet income = Total revenue β Total expensesGross profit = Revenue β COGS Β· Operating income = Gross profit β OpExGross margin = Gross profit Γ· RevenueMarginal cost = ΞTotal cost Γ· ΞOutputAvg total cost = Total cost Γ· total patients (efficient output = min ATC)Profit-maximizing output: Price β₯ Marginal cost1 FTE = 40 Γ 52 = 2,080 hrs/yr Β· 7-day coverage factor = 1.4Turnover = new hires Γ· total FTEsCOGS = Beginning inv + Purchases β Ending invNet Book Value = Original cost β Reserve for DepreciationOccupancy = patient days Γ· available days Β· Asset turnover = revenue Γ· book value
| Number | Meaning |
|---|---|
| 17.6% GDP Β· ~$14,570/capita | U.S. health spending (2023); ranks last in outcomes |
| 80β85% / 98% | ACA-required MLR / Medicare's spend on care |
| $21.88 (2023) β $20.49 (2026) | Anesthesia reimbursement per unit; Medicare = 33% of commercial |
| 2β4 = QK Β· >4 = AD Β· 1 = QY Β· GC = teaching | Medical direction/supervision ratios; GC = MDA teaching resident |
| QZ = 100% Β· QX/QK = 50% | CRNA independent vs. directed payment |
| 7 | TEFRA steps (for MDA payment; NOT for CRNA, NOT standards of care) |
| 15 min = 1 time unit | Anesthesia time (Γ·15, round to 1 decimal) |
| CF: avg $21.99 Β· hi $27.86 AK Β· lo $20.32 PR/USVI | Medicare conversion factor range |
| 30 days / 48 hrs | Pre-anesthetic eval window / update requirement |
| Part A vs Part B | Physician supervision (opt-out) vs. medical direction/supervision |
| 123% Β· 46% | CMS pays MA vs. traditional Β· UHC+Humana share of MA |
| CAA 2021 Β· 1/1/2022 Β· ~$400 | No Surprises Act origin/effective Β· IDR loser fee |
| +5 / +2 / +1 | Qualifying circ: hypotension/hypothermia / emergency / extreme age (ABU) |
| P3=1, P4=2, P5=3 | Physical status additional base units |
| 3.4 / million | Six Sigma defect target |
| 80/20 | Pareto principle |
| 75% life / 90% PV | Capital-lease capitalization criteria |
| ~46% / ~38% / ~16% | RFP reasons: service / cost / leadership |
| β3.8% | 2022 median U.S. hospital operating margin |
| 1992 | RBRVS adopted; RUC advises, CMS decides |
| Form 2553 Β· 1099-NEC Β· K-1 | S-corp election Β· IC income Β· shareholder profit/loss |
Click each question to reveal the answer & rationale. These mirror the scenario style of the Quiz-1 review.